All about Russia’s ‘Sputnik V’ and its availability

Ever since Russia dropped the bombshell announcement of giving a regulatory approval for the “Sputnik V” vaccine for Covid-19 on Tuesday, the development has been met by scepticism. One of the biggest concerns is that the approval comes before the completion of human trials. Russia was yet to start a larger trial involving thousands of participants, commonly known as a Phase III trial, which is normally considered an essential precursor to a regulatory approval.

Russian President Vladimir Putin claims the vaccine offers “sustainable immunity” against Covid-19. He said one of his daughters had received the inoculation and felt better.